Status:
RECRUITING
Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer
Lead Sponsor:
Institut du Cancer de Montpellier - Val d'Aurelle
Conditions:
Pancreas Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Specifically, in this project, the objective will be developped a model to capture imaging-based tumor heterogeneity with multiscale radiomics approach by obtaining the mirror tumor image at in vivo M...
Detailed Description
With a five-year survival rate of only 3% for the majority of patients, pancreatic cancer is a global healthcare challenge. By the time of diagnosis over half of pancreatic cancers are metastasized. T...
Eligibility Criteria
Inclusion
- Patient aged \>18 2.
- Pathologically proven pancreatic cancer which can beneficiate of upfront surgery or delayed surgery followed by neoadjuvant chemotherapy.
- Negative pregnancy test for women of childbearing potential
- Patients affiliated to a social protection system
- Written informed consent signed before project onset.
Exclusion
- presence of metastases,
- Patient who will not have surgery
- Pregnant or breastfeeding women
- Mental or psychological state, physical or legal incapacity preventing participation in the project.
Key Trial Info
Start Date :
December 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2029
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06144762
Start Date
December 19 2023
End Date
October 1 2029
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NOUGARET Stephanie
Montpellier, France, 34298